Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
January 18, 2014
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Peter S Dragovich, Guiling Zhao, Timm Baumeister, et al.
Journal of Medicinal Chemistry
|
April 27, 2013
Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors
Xiaozhang Zheng, Paul Bauer, Timm Baumeister, et al.
Journal of Medicinal Chemistry
|
February 17, 2012
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties
Simon Mathieu, Stefan N Gradl, Li Ren, et al.
Journal of Medicinal Chemistry
|
January 11, 2014
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Anthony M Giannetti, Xiaozhang Zheng, Nicholas J Skelton, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 4, 2015
Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility
Mark Zak, Bianca M Liederer, Deepak Sampath, et al.
Journal of Medicinal Chemistry
|
July 18, 2013
Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors
Xiaozhang Zheng, Paul Bauer, Timm Baumeister, et al.
Journal of Medicinal Chemistry
|
May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy
Dillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
Mark Zak, Emily J Hanan, Patrick Lupardus, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2013
Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties
Janet Gunzner-Toste, Guiling Zhao, Paul Bauer, et al.
Journal of Medicinal Chemistry
|
December 12, 2017
Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity
BinQing Wei, Janet Gunzner-Toste, Hui Yao, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Bioorganic & Medicinal Chemistry Letters
|
January 18, 2014
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Peter S Dragovich, Guiling Zhao, Timm Baumeister, et al.
Journal of Medicinal Chemistry
|
April 27, 2013
Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors
Xiaozhang Zheng, Paul Bauer, Timm Baumeister, et al.
Journal of Medicinal Chemistry
|
February 17, 2012
Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties
Simon Mathieu, Stefan N Gradl, Li Ren, et al.
Journal of Medicinal Chemistry
|
January 11, 2014
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)
Anthony M Giannetti, Xiaozhang Zheng, Nicholas J Skelton, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 4, 2015
Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility
Mark Zak, Bianca M Liederer, Deepak Sampath, et al.
Journal of Medicinal Chemistry
|
July 18, 2013
Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors
Xiaozhang Zheng, Paul Bauer, Timm Baumeister, et al.
Journal of Medicinal Chemistry
|
May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy
Dillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
Mark Zak, Emily J Hanan, Patrick Lupardus, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2013
Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties
Janet Gunzner-Toste, Guiling Zhao, Paul Bauer, et al.
Journal of Medicinal Chemistry
|
December 12, 2017
Discovery of Peptidomimetic Antibody-Drug Conjugate Linkers with Enhanced Protease Specificity
BinQing Wei, Janet Gunzner-Toste, Hui Yao, et al.
Page
of 10